Hydrogen chloride-ethyl acetate → 8-(1,2-Dimethylpropoxy)-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine hydrochloride

HRID 2191257

反応式

HRID 2191257 の反応式
[CH3:1][CH:2]([O:6][C:7]1[CH:8]=[CH:9][C:10]2[CH2:11][N:12](C(OC(C)(C)C)=O)[CH2:13][CH2:14][O:15][C:16]=2[N:17]=1)[CH:3]([CH3:5])[CH3:4].[ClH:25].C(OCC)(=O)C>>[ClH:25].[CH3:1][CH:2]([O:6][C:7]1[CH:8]=[CH:9][C:10]2[CH2:11][NH:12][CH2:13][CH2:14][O:15][C:16]=2[N:17]=1)[CH:3]([CH3:4])[CH3:5]

参加物

3

実験手順

A mixture of the compound obtained in step 1 (0.36 g) and 4N hydrogen chloride/ethyl acetate (10 mL) was stirred at room temperature for 3 hr. The precipitate was collected by filtration, and the aqueous layer was basified and extracted with ethyl acetate and aqueous sodium hydroxide solution. The organic layer was washed with saturated brine and dried, and the solvent was evaporated under reduced pressure. Ethyl acetate was added to the residue, and 4N hydrogen chloride/ethyl acetate was added. The precipitate was collected by filtration and recrystallized from ethanol-diisopropyl ether to give the title compound (0.15 g, 52%) as a white powder.

後処理

  1. filtrationThe precipitate was collected by filtration
  2. extractionextracted with ethyl acetate and aqueous sodium hydroxide solution
  3. washThe organic layer was washed with saturated brine
  4. customdried
  5. customthe solvent was evaporated under reduced pressure
  6. additionEthyl acetate was added to the residue, and 4N hydrogen chloride/ethyl acetate
  7. additionwas added
  8. filtrationThe precipitate was collected by filtration
  9. customrecrystallized from ethanol-diisopropyl ether

出典と根拠

ORDレコード
ord-2a070a86010246e1b5d44d08b45a8049
出典データセット
uspto-grants-2012_12
特許番号
US08329687B2

関連ノート

読み込み中…